Phytate, reactive oxygen species and colorectal cancer

被引:9
|
作者
Owen, RW [1 ]
Spiegelhalder, B [1 ]
Bartsch, H [1 ]
机构
[1] German Canc Res Ctr, Div Toxicol & Canc Risk Factors, D-69120 Heidelberg, Germany
关键词
cell proliferation; colorectal cancer; faeces; high-performance liquid chromatography; hypoxanthine; minerals; phytic acid; reactive oxygen species; salicylic acid; xanthine oxidase;
D O I
10.1097/00008469-199805000-00008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Reproducible high-performance liquid chromatography methods have been developed and validated which allow an accurate quantification of phytic acid in faeces and food and reactive oxygen species in an in vitro model system and in faecal specimens. When applied to the evaluation of reactive oxygen species generation by faeces, this method has shown that 1:100 dilutions of matrix obtained from stool samples of adenoma patients are capable of generating significant quantities of reactive oxygen species as evinced by the production of diphenols from salicylic acid, Moreover, it has been shown that the major product of HO. attack on salicylic acid is 2,5-dihydroxy benzoic acid and not 2,3-dihydroxy benzoic acid as previously reported. In the presence of the antioxidant ascorbic acid the inhibitory capacity of phytic acid on the generation of reactive oxygen species is completely subverted, Therefore, the kinetics of reactive oxygen species production by faeces is currently under further investigation by high-performance liquid chromatography and chemiluminescence in various patient groups and may give an insight into the role of reactive oxygen species in the aetiology of colorectal cancer. Eur J Cancer Prev 7 (suppl 2): S41-S54 (C) 1998 Lippincott-Raven Publishers.
引用
收藏
页码:S41 / S54
页数:14
相关论文
共 50 条
  • [41] The role of cellular reactive oxygen species in cancer chemotherapy
    Haotian Yang
    Rehan M Villani
    Haolu Wang
    Matthew J Simpson
    Michael S Roberts
    Min Tang
    Xiaowen Liang
    Journal of Experimental & Clinical Cancer Research, 37
  • [42] Interplay Between Reactive Oxygen Species and MicroRNAs in Cancer
    He J.
    Jiang B.-H.
    Current Pharmacology Reports, 2016, 2 (2) : 82 - 90
  • [43] Reactive oxygen species and cancer paradox: To promote or to suppress?
    Galadari, Sehamuddin
    Rahman, Anees
    Pallichankandy, Siraj
    Thayyullathil, Faisal
    FREE RADICAL BIOLOGY AND MEDICINE, 2017, 104 : 144 - 164
  • [44] AQUAPORINS AND REACTIVE OXYGEN SPECIES IN INFLAMMATORY BREAST CANCER
    Saripalli, Anand
    Dajani, Salah D.
    Repak, Miroslava
    Sharma-Walia, Neelam
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (05) : 911 - 911
  • [45] The emerging role of reactive oxygen species in cancer therapy
    Renschler, MF
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (13) : 1934 - 1940
  • [46] Pharmacological Modulation of Reactive Oxygen Species in Cancer Treatment
    Ribas, Judit
    Mattiolo, Paolo
    Boix, Jacint
    CURRENT DRUG TARGETS, 2015, 16 (01) : 31 - 37
  • [47] Reactive Oxygen Species in Cancer Biology and Anticancer Therapy
    Bazhin, Alexandr V.
    Philippov, Pavel P.
    Karakhanova, Svetlana
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2016, 2016
  • [48] Chemiluminescence assay of reactive oxygen species in laryngeal cancer
    Baglam, T.
    Sari, M.
    Yazici, Z. Mine
    Yuksel, M.
    Uneri, C.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2010, 124 (10): : 1091 - 1094
  • [49] Role of reactive oxygen species in immune suppression in cancer
    Corzo, Cesar Alexander
    Nagaraj, Srinivas
    Kusmartsev, Sergei
    Gabrilovich, Dmitry
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [50] The role of cellular reactive oxygen species in cancer chemotherapy
    Yang, Haotian
    Villani, Rehan M.
    Wang, Haolu
    Simpson, Matthew J.
    Roberts, Michael S.
    Tang, Min
    Liang, Xiaowen
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37